Monogram Technologies (DB:J7J) - Stock Price, News & Analysis

J7J Stock Overview

Focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants.

J7J fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Revenue is forecast to grow 128.32% per year

Risk Analysis

Makes less than USD$1m in revenue ($365K)

Highly volatile share price over the past 3 months

Currently unprofitable and not forecast to become profitable over the next 3 years

Shareholders have been diluted in the past year

+ 1 more risk

Monogram Technologies Inc. Competitors

NanoRepro

XTRA:NN6

€22.9m

PULSION Medical Systems

MUN:PUS

€131.9m

Geratherm Medical

XTRA:GME

€21.7m

Stratec

XTRA:SBS

€533.0m

Price History & Performance

Summary of all time highs, changes and price drops for Monogram Technologies
Historical stock prices
Current Share Price	US$2.02
52 Week High	US$4.40
52 Week Low	US$1.33
Beta	0
11 Month Change	-24.06%
3 Month Change	16.09%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-34.82%

Recent updates

Shareholder Returns

	J7J	DE Medical Equipment	DE Market
7D	-25.2%	3.1%	1.0%
1Y	n/a	4.8%	11.2%

Return vs Industry: Insufficient data to determine how J7J performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how J7J performed against the German Market.

Price Volatility

Is J7J's price volatile compared to industry and market?
J7J volatility
J7J Average Weekly Movement	22.1%
Medical Equipment Industry Average Movement	5.0%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: J7J's share price has been volatile over the past 3 months.

Volatility Over Time: J7J's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
2015	28	Ben Sexson	www.monogramorthopedics.com

Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.

Monogram Technologies Inc. Fundamentals Summary

How do Monogram Technologies's earnings and revenue compare to its market cap?
J7J fundamental statistics
Market cap	€69.21m
Earnings (TTM)	-€10.46m
Revenue (TTM)	€326.56k

218.0x

P/S Ratio

-6.8x

P/E Ratio

Is J7J overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
J7J income statement (TTM)
Revenue	US$365.00k
Cost of Revenue	US$0
Gross Profit	US$365.00k
Other Expenses	US$12.06m
Earnings	-US$11.69m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.37
Gross Margin	100.00%
Net Profit Margin	-3,203.88%
Debt/Equity Ratio	0%

How did J7J perform over the long term?

See historical performance and comparison

Monogram Technologies DB:J7J Stock Report